Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104).
Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104). J Transl Med. 2012 Dec 10; 10:246.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Biopsy
Cell Line, Tumor
Enzyme Inhibitors
Extracellular Signal-Regulated MAP Kinases
Farnesyltranstransferase
Female
HSP40 Heat-Shock Proteins
Humans
Interferon-gamma
Male
Melanoma
Middle Aged
Neoplasm Staging
Phosphorylation
Proto-Oncogene Proteins c-akt
Quinolones
Signal Transduction
Skin Neoplasms
T-Lymphocytes
Treatment Outcome
authors with profiles
Thomas F. Gajewski